A dominant gene carried in certain inbred mouse strains confers susceptibility to tumors induced by polyoma virus. This gene, designated Pyv s, was defined in crosses between the highly susceptible C3H/BiDa strain and the highly resistant but H-2k-identical C57BR/cdJ strain. The resistance of C57BR/cdJ mice is overcome by irradiation, indicating an immunological basis. In F1 x C57BR/cdJ backcross mice, tumor susceptibility cosegregates with Mtv-7, a mouse mammary tumor provirus carried by the C3H/BiDa strain. This suggests that Pyv s might encode the Mtv-7 superantigen (SAG) and abrogate polyoma tumor immunosurveillance through elimination of T cells bearing specific VB domains. DNA typing of 110 backcross mice showed no evidence of recombination between Pyv s and Mtv-7. Strongly biased usage of VB6 by polyoma virus-specific CD8 § cytotoxic T lymphocytes in C57BR/cdJ mice implicates T cells bearing this Mtv-7 SAG-reactive VB domain as critical anti-polyoma tumor effector cells in vivo. These results indicate identity between Pyv s and Mtv-7 sag, and demonstrate a novel mechanism of inherited susceptibility to virus-induced tumors based on effects of an endogenous superantigen on the host's T cell repertoire.
D
evelopment of neoplastic disease requires that a cell first become transformed and then be able to evade the host's immune system. The importance of an intact immune system in preventing overt neoplastic disease is highlighted by the increased incidence of malignancies in immunocompromised individuals (1) . Tumor cell variants that escape immunosurveillance can emerge in immunocompetent hosts, and various mechanisms of immune evasion at the level of the tumor celt have been documented (2) (3) (4) (5) (6) . In principle, transformed cells expressing neoantigens might also escape immune recognition due to a hole in the host's T cell repertoire. Such a phenomenon involving defective tumor-specific T cell responses in otherwise immunocompetent hosts has, to our knowledge, not been reported. Results presented here on susceptibility of the mouse to polyoma virus-induced tumors provide the first evidence for a genetically dominant mechanism of this kind.
Polyoma virus is a potent oncogenic agent capable of inducing multiple solid tumors in the mouse, its natural host (7, 8) . For over three decades the polyoma-mouse system has served as a model for investigations of immune responses to virus-induced cancers. Early studies using neonatally thymectomized mice, nude mice, and adoptive transfer of polyoma virus-immune splenocytes showed that resistance to polyoma tumors is mediated by T cells (9) (10) (11) . Although the primary effector T cell mediating resistance to polyoma tumors has not been fully defined, CD8 § CTLs specific for syngeneic cells expressing polyoma tumor-specific transplantation antigen(s) (TSTAs) 1 are known to be induced by polyoma infection (12) .
MHC molecules as well as products of non-MHC genes control susceptibility to polyoma-induced tumors. In crosses between MHC-nonidentical strains differing in susceptibility, resistance is inherited in a dominant or codominant manner determined largely by the MHC difference itself (9, 13) . Interestingly, the opposite pattern of inheritance is seen in crosses between MHC-identical (H-2 k) mice where susceptibility rather than resistance is dominant (13) . In crosses between the highly susceptible C3H/BiDa mouse and the highly resistant but MHC-identical C57BK/cdJ mouse, susceptibility is conferred by a single autosomal dominant gene which we have designated Pyv s (14) .
Evidence presented here strongly suggests that Pyv s is the 1Abbreviations used in this paper: LT, large T protein; MT, middle T protein; Mtv, mouse mammary tumor virus; PyvS, polyoma tumor susceptibility gene; SAG, superantigen; SSR, simple sequence repeat; TFI, tumor frequency index; TIL, tumor-infiltrating lymphocyte; TSTA, tumorspecific transplantation antigen.
endogenous superantigen encoded by the mouse mammary tumor provirus Mtv-7. Mouse mammary tumor virus (Mtv) superantigens (SAG) are type II transmembrane glycoproteins (15, 16) encoded by an open reading frame in the YLTK of the provirus (17, 18) . Like bacterial superantigens, Mtv SAGs associate with class II MHC molecules and bind to the variable domain of the fl-chain (V~) of the TCR (19) . A polymorphic region in the carboxy terminus of Mtv SAGs determines its VB domain specificity (20) . As self-proteins, Mtv SAGs alter the peripheral T cell repertoire by intrathymic deletion of VB-reactive T cells (21) (22) (23) (24) . Results of genetic and immunological experiments indicate Pyv s is Mtv-7 sag and induces susceptibility to the oncogenic effects of the virus by deleting precursors of polyoma TSTA-specific T cells.
Materials and Methods
Mice. C57BR/cdJ, C3H/HeJ, CBA/J, CBA/CaJ, and RF/J mice were purchased from the Jackson Laboratory (Bar Harbor, ME). C3H/BiDa mice were purchased from the Frederick Cancer Research and Development Center of the National Cancer Institute (Frederick, MD). Newborn mice (<18 h of age) were inoculated intraperitoneally with molecularly cloned and plaque-purified polyoma virus, and examined for tumors as described (8, 14) .
6-wk-old C57BR/cdJ female mice received 800 or 900 rads of "y-radiation in a Gammacell 40 (Atomic Energy of Canada, Ltd., Ottawa, Canada), and, 24 h later, were inoculated intraperitoneally with virus. A cell line was established from a salivary tumor arising in one of these mice. This cell line expressed full-length small T and middle T (MT) proteins, a truncated large T (LT) protein (25) , and no polyoma VP1 capsid protein.
Polyoma tumors carried by serial passage in normal C57BR/cdJ mice were finely minced and injected subcutaneously in 0.25-ml vol into 6-8-wk-old C57BR/cdJ mice that had been inoculated at birth with polyoma virus.
Cytofluorometric Analysis. Viable mononuclear cells from spleens or lymph nodes were isolated on LSM (Organon Teknika, Rockville, MD). Spleen cells were subsequently enriched for T cells on nylon wool columns as described (26) . Cells were indirectly stained with FITC-conjugated goat anti-hamster IgG or FITC-conjugated goat anti-rat IgG F(ab')2 secondary antibodies (Caltag Laboratoties, South San Francisco, CA) and culture supernatants of the following hybridomas: B20.6, recognizing V32 (from B. Malissen, Centre d'Immunologie de Marseille-Luminy, France); KJ25, recognizing VB3 (from P. Marrack andJ. Kappler, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO); 44-22-1, recognizing V36 (from H. Hengartner, Institute of Pathology, University Hospital, Zurich, Switzerland); TR310, recognizing V37 (from C. Okada, Stanford University School of Medicine, Stanford, CA); R14-2, recognizing V314 (from D. Raulet, University of California, Berkeley, CA); and H57-597, recognizing o~3-TCR (from R. Kubo, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO). PE-conjugated anti-CD4 and anti-CD8 antibodies were purchased from Caltag Laboratories. Cells were analyzed on a flow cytometer (Epics Profile II; Coulter, Hialeah, FL).
Mtv-7 Southern Hybridization and SSR Mapping. Genomic liver DNA was isolated as described (27) . Eco RI-digested genomic DNA was analyzed by Southern hybridization for the presence of Mtv-7 as described (28 Isolation of TILs. A 5-wk-old C57BR/cdJ male inoculated at birth with A2 virus was injected subcutaneously with 13 x 106 cells of the C57BK/cdJ polyoma tumor cell line (see above). 15 d later, the tumor was resected, minced, and digested with 500 U/ml coUagenase (ICN Biomedicals, Inc., Costa Mesa, CA) for 1 h at 37~ Nonadherent cells were collected following two rounds of incubation in plastic petri dishes (Nunc, Roskilde, Denmark) for 1 h at 37~ and 7% CO2. Viable mononuclear cells were isolated on LSM (Organon Teknika, Durham, NC), incubated for 16 h at 37~ and 7% COz in complete medium, then stained and analyzed by cytofluorometry. No differences in CD4, CD8, or V/3 expression were found between T cells analyzed immediately after isolation from either the polyoma tumor or normal C57BK/cdJ lymph nodes and those analyzed following 16-h incubation in complete medium (data not shown). These TILs were established as a line by weekly passage with virus-infected, irradiated C57BR/cdJ spleen cells for 8 wk.
Cytotoxicity Assays. The CytoTox 96 nonradioactive assay (Promega, Madison, WI) was used with TCMK-1 (H-2 k) target cells (American Type Culture Collection, Kockville, MD) to assay cytotoxic activity by the tertiary culture of polyoma-immune T cells (see Fig. 3 ). The assay was carried out according to manufacturer's directions using 1 x 104 TCMK-1 cells per well of 96-well U-bottom microtiter plates, except that the assay medium was phenol red-free AIM V medium (GIBCO BRL, Gaithersburg, MD). TCMK-1 cells were either left uninfected or infected with virus (multiplicity of infection = 10) for 20 h before use in the assay. Spontaneous release of lactate dehydrogenase was *10% for uninfected and infected cells over a 4-h assay at 37~ and 7% CO2.
To assay cytotoxic activity by the TIL line (see Fig. 5 ), SlCrrelease assays were performed as described by Gooding (31) , using C57BR/cdJ polyoma tumor cells and SV40-transformed (H-2 k) PSC3H cells as targets. These target cells were incubated with 100 U/ml recombinant mouse interferon-'y (Genzyme, Cambridge, MA) for 48 h before use in the assay. Spontaneous release of SlCr was 16% for PSC3H cells and 26% for polyoma tumor cells over a 6-h assay at 37~ and 7% CO2.
Percent specific lysis for each assay was determined from quadruplicate samples. Standard errors of the mean value were always <5% of mean values and are omitted.
Results

Resistance of the C57BR/cdJ Mouse to Polyoma Tumors
Has an Immunological Basis. C57BK/cdJ mice are pyvS-negative and highly resistant to tumors induced by polyoma virus, while C3H/BiDa mice are PyvS-positive and highly susceptible. Despite this difference, neonatally infected mice of both strains develop disseminated infections, and cells from the resistant C57BR/cdJ mouse are readily transformed by polyoma T antigens in vitro (14) . It thus appears that Pyv s is not essential for replication or transformation by the virus, but rather acts in some systemic manner to allow development of tumors. One model consistent with these observations is that Pyv s acts to prevent an effective immune response to polyoma tumors. Such a model would imply that the resistance of C57BK/cdJ mice has an immunological basis and that these mice would become susceptible if immunosuppressed. Results shown in Table 1 confirm this expectation.
Tumors developed in 100% of adult C57BK/cdJ mice irradiated before virus inoculation, while the same dose of virus induced tumors in less than 5% of unirradiated newborn C57BK/cdJ mice. This difference is due to irradiation and not to the age difference between the two groups, since newborn mice of even the most susceptible strains are known to become resistant as adults (7, 32) . Irradiated mice uniformly developed bilateral salivary gland tumors at 7-8 wk postinfection; mammary gland tumors, thymic epitheliomas and an ameloblastoma were also seen in this group of animals. Peripheral blood smears taken at necropsy showed severe leukopenia, and immunobtots of tumors were clearly positive for viral T antigens and capsid proteins, confirming that the tumors arose in immunosuppressed hosts and were virusinduced.
The two positive animals in the nonirradiated group each developed a single gross tumor. This contrasts with the development of multiple gross tumors per animal typically seen in PyvS-positive mouse strains such as C3H/BiDa (8, 33) . These C57BR/cdJ tumors, both of mammary gland origin, were composed of sheets of spindle-shaped cells and differed histologically from the comedo-type intraductal carcinoma typically seen in C3H/BiDa mice (34) . It seemed possible that these unusual tumors arising in immunocompetent mice were variants that somehow escaped immunosurveillance. To test this possibility, the tumors were injected subcutaneously into adult C57BK/cdJ mice that had been inoculated at birth with polyoma virus. Both tumors transplanted readily to these polyoma-immune hosts, indicating that they were indeed immune escape variants. As a control, a tumor that arose in an irradiated C57BK/cdJ mouse (and was therefore not subject to immune selection) was tested; this tumor was rejected by polyoma-immune C57BR./cdJ mice as expected, but did " Unirradiated C57BK/cdJ mice were inoculated at birth with polyoma virus. Adult C57BK/cdJ mice were "),-irradiated (800-900 rads) and inoculated with polyoma virus 24 h later. Mice were necropsied when moribund, or at 6 mo after infection, and tissue sections examined histologically. Adult C57BR/cdJ mice that had been inoculated with polyoma virus at birth were injected subcutaneously with minced tumor suspensions. Tumors from both of the unirradiated and from one of the irradiated polyoma-infected C57BR/cdJ mice (a) were maintained by serial passage in C57BK/cdJ mice before transplantation. Mice were scored for gross tumors 2 wk after transplantation. transplant readily to nonimmune C57BR/cdJ mice. These results show that the C57BK/edJ mouse is capable of mounting an effective immune response to polyoma tumors, and that rare tumors which arise in this strain are variants that escape immune recognition.
Tumor Susceptibility and Mtv-7 Cosegregate in Backcross Mice. Given that Pyv s determines susceptibility in F1 hybrids between C3H/BiDa and C57BK/cdJ mice, it must act in some way to negate the immune response contributed by the C57BK/cdJ parent. We hypothesize that Pyv s encodes an Mtv SAG that deletes T cells required for protection against polyoma tumors. Comparison of the Mtv proviruses carried by these strains suggests two candidates, Mtv-6 and Mtv-7, based on their presence in C3H/BiDa and absence in C57BK/cdJ mice ( Table 2) . Mtv-17 is not considered because a mutation in its LTR most likely prevents expression (45) , and no deletion of T cells bearing the expected V/3 specificity has been found (44) . Anti-polyoma T cells in the resistant C57BK/cdJ mouse would therefore be predicted to express either V/33 if Pyv s were Mtv-6 sag, or VB6 and/or V/37 if Pyv s were Mtv-7 sag. Expression of other VB domains targeted by Mtv-6 sag (V/35) or Mtv-7 sag (V/38.1 and V/39) is excluded since the coding regions for these segments are absent from the germline in C57BK/cdJ mice (37) .
To determine if tumor susceptibility cosegregates with either Mtv-6 or Mtv-7, 35 backcross (F1 x C57BK/cdJ) mice presence (or absence) of Mtv-7. The remaining five animals showed the expected concordance between inheritance of Mtv-7 and absence of V36 + T cells, but were dearly nonconcordant with respect to Mtv-7 and tumor phenotype. The analysis was extended to an additional 84 backcross mice which were typed for Mtv-7. The combined data for all 119 mice are presented in Table 4 . The association between Pyv s and Mtv-7 is highly significant, with 102 animals (86%) showing concordance between Mw-7 and Pyv s. Chisquare analysis gives a probability of << 0.005 that these results would arise by chance, assuming no association between these genes. 17 backcross mice (14%) were nonconcordant. Eight of these were Mtv-7-but tumor-bearing. Interestingly, only single tumors were found in these mice, as was the case with the rare C57BR/cdJ parental mice that developed tumors. This contrasts with the majority of the Mtv-7 + backcross mice which developed multiple tumors ( Table 4 (29) were sought as markers to detect recombination on either side of Mtv-7. SSR probes known to map to the distal region of chromosome 1 (map obtained from Research Genetics, Inc., Huntsville, AL) were screened, and two appropriate markers identified.
The DNAs from 110 backcross mice were typed for the SSR markers by PCIL and for Mtv-7 by Southern hybridization. Based on their frequencies of recombination with Mtv-7, the SSR markers are located '~10 cM on either side of the provirus (Fig. 1) . Significantly, the fraction of mice that was recombinant in each of these intervals was roughly the same for the nonconcordant and concordant groups, i.e., in the range of 6-12% (Table 5) . These results do not support the possibility that Pyv s and Mtv-7 are separate genes, since this would require that the nonconcordant mice show a much higher frequency of recombination ('~70% if the genes were 14 cM apart) in one of the two intervals. 
V~6 Is Used Preferentially by Polyoma-specific T Cells.
If Pyv s is Mtv-7 sag, then its action in determining susceptibility to polyoma tumors is expected to be based on the elimination of T cells bearing either V36 or V37 domains. Likewise, resistance in the C57BR/cdJ mouse should be mediated by T cells bearing one, or possibly both, of these V3 domains. To test this prediction, T cells taken from lymph nodes of polyoma virus-infected C57BR/cdJ mice were stimulated twice in vitro with virus-infected, irradiated syngeneic spleen cells, and then analyzed for V3 usage as well as for expression of CD4 and CD8. As shown in Fig. 2 , the majority of these T cells expressed V36 (76%) and were CD8 + (95%); no other V3 type was elevated, including V37. T cells from lymph nodes of normal C57BR/cdJ mice were only 15% V36 § This experiment was repeated with separate cultures from eight C57BR/cdJ mice, with the same general results. VB6-usage ranged from 33 to 100%, while usage of V3s 2, 3, 7, and 14 remained low (~<10%). A tertiary culture composed of >98% CD8 + V36 + T cells lysed polyoma virus-infected but not uninfected H-2 k target cells (Fig. 3) .
Biased usage of V36 was also observed in polyoma tumor- usage of V36 by polyoma-specific CTLs in the resistant C57BR/cdJ mouse, and support the conclusion that Pyv s is indeed Mtv-7 sag acting to delete V36 + T cells in the susceptible C3H/BiDa mouse.
infiltrating lymphocytes (TILs), as follows. A C57BR/cdJ mouse immunized at birth with virus was injected subcutaneously with a large dose (13 x 106) of cells from a polyoma tumor that arose in an irradiated C57BR/cdJ animal (see Table  1 b). Two weeks later, the tumor was harvested and the infiltrating T cells were recovered and analyzed. Roughly 80% of the TILs were CD8 + and nearly half of these expressed V~6 (Fig. 4) . In contrast, only 14% of CD4 + TILs expressed V36. A line was established from TILs by repeated passage in vitro in the presence of infected, irradiated stimulator cells. This line, containing >95% CDS+Vfl6 + cells, exhibited cytolytic activity against C57BR/cdJ polyoma tumor cells but not against an SV40-transformed H-2 k cell line (Fig. 5) . These results confirm the expectation of preferential
Discussion
The polyoma tumor susceptibility gene Pyv s acts by preventing the host from mounting an effective immune response to virus-induced tumors. In a majority of mice from a cross in which Pyv s and the mouse mammary tumor provirus Mtv-7 are segregating, tumor development cosegregates with the provirus. The known role of Mtv-7 SAG in deleting V~6 + T cells provides a plausible mechanism of action for Pyv s.
We have argued against the possibility of linkage and in favor of identity between Pyv s and Mtv-7 sag on two grounds. The first is genetic, based on the fact that phenotypically nonconcordant backcross mice-those that are either 5O _o activity. An in vitro tertiary culture of polyoma virus-immune C57BR./cdJ cells derived as in Fig. 2 and composed of >98% CD8 + V36 + T cells, was assayed for lytic activity against uninfected (-O-) and polyoma virusinfected (--~-) H-2 k target cells. tumor-free and Mtv-7 + , or tumor-bearing and Mtv-7--are not selectively recombinant in the region of chromosome 1 flanking Mtv-7. Recombinant backcross mice were found at equal frequencies in the nonconcordant and concordant groups, and not preferentially in the former group as would be expected if Pyv s and Mtv-7 were separate linked genes. The second is immunological, and is based on deletion of V/~6 § T cells by Mtv-7 sag in the susceptible C3H/BiDa mouse coupled with strongly biased usage of V/36 by polyoma-specific T cells in the resistant C57BR/cdJ mouse. T cells from polyoma-primed C57BR/cdJ mice stimulated in vitro, as well as those recovered from a polyoma tumor carried in a virusimmune C57BR/cdJ host, are predominantly CD8+V~6 + . These cells possess virus-specific cytolytic activity. Several factors may be cited to explain the appearance of nonconcordant mice, all consistent with Pyv s being Mtv-7 sag. Approximately 7% of backcross mice were scored as tumor-free through they clearly inherited Mtv-7. These mice can be explained, at least in part, by the fact that Pyv s is less than 100% penetrant; in repeated experiments with groups of '~30 C3H/BiDa mice, the frequency of tumor induction is between 95 and 100%. In addition, the chance of misphenotyping backcross mice as tumor-free is elevated because the average number of tumors per affected animal, termed the tumor frequency index (TFI), is lower in these mice compared to (C3H/BiDa x C57BR/cdJ)F1 mice. The TFI for backcross mice was 2.9 (131 tumors among 45 mice) and for F1 mice 4.6 (207 tumors among 45 mice). There could also be other effects attributed to the C57BR/cdJ genetic background which might, for example, cause a slower deletion of T cells by Mtv-7 sag. Delayed T cell deletion by an endogenous superantigen may allow specific antigen to block deletion of antigen-specific T cells bearing superantigen-reactive V~ domains (46) . Any or all of these factors could result in the failure of Mtv-7 + backcross mice to be scored as tumor-bearing. With respect to the 7% of backcross mice which developed tumors without inheriting Mtv-7, the most plausible explanation is that these tumors represent immune escape variants as has been shown for the rare tumors in C57BR/cdJ mice (Table 1) . This interpretation is supported by the fact that only single tumors were found in these nonconcordant backcross mice (Table 4) .
While the identification of Pyv s as Mtv-7 sag has been based on analyses of crosses between C3H/BiDa and C57BR/ cdJ mice, additional support comes from the known distributions of Mtv proviruses and polyoma tumor susceptibilities among other mouse strains. Historically (7) and in our own hands (13) , mice possessing the highest susceptibility to tumor induction by polyoma all possess the H-2 k haplotype. Not all H-2 k mice are highly susceptible, however. As shown in Table 6 , the correlation of high susceptibility with Mtv-7 and with no other Mtv provirus is clear. The combination of H-2 ~ and Mtv-7 as interactive codeterminants of susceptibility also reflects the hierarchy of presentation of Mtv-7 SAG by class II MHC molecules of different haplotypes: k > d > b > > q (22, 47) .
Our results implicate CD8+V/36+CTL as critical antipolyoma effector T cells in H-2 k Mtv-7-mice inoculated with virus as newborns. However, H-2 k Mtv-7 + mice, which are susceptible as newborns, are known to develop resistance soon after birth (7) . This implies that non-V~6-bearing T cells are involved in polyoma tumor immunity in C3H/BiDa mice inoculated as young adults.
Most Mtv SAGs, including Mtv-7 SAG, negatively select CD8 + as well as CD4 + thymocytes despite the requirement for association of Mtv SAGs with class II MHC molecules (23) . Clonal deletion of CD4 + CD8 + thymocytes has been put forward to explain Mtv SAG-mediated deletion of VB- (19) . High susceptibility strains have a >95% tumor incidence and develop multiple tumors of diverse types; low susceptibility strains have a lower tumor incidence and generally develop single tumors per animal (7, 13 , and unpublished data).
reactive peripheral CD8 + T cells (23, 48, 49) . However, the finding that Mtv-7 + mice expressing a transgene encoding a class I MHC-restricted V38.1-TCR delete mature single CD8 + but not CD4+CD8 + thymocytes indicates that Mtv-7 SAG can act in thymocyte maturation at a point beyond the CD4+CD8 + stage (50) . In addition, Mtv-7 + CD4-knockout mice delete CD8 + T cells bearing V36, 8.1, and 9, but not V37 which has the lowest affinity for Mtv-7 SAG (51), implying that CD4 expression may be required for clonal deletion only when Mtv SAG-TCR affinity is low (52) .
In another system, a novel Mtv-SAG contributes to development of spontaneous B cell lymphomas in SJL mice. In this case, the Mtv-SAG stimulates CD4+V316 + T cells to release cytokines required for tumor growth (53, 54) . While endogenous Mtv-SAGs are required for tumor development in both this and the polyoma system, the strategies are clearly different, involving stimulation of CD4 § T cells in one case and deletion of CD8 + T cells in the other.
Biased usage of V36 by polyoma-specific CTL suggests that these T cells recognize few, and perhaps a single, viral peptide(s) associated with a particular H-2 ~ class I molecule. A growing body of evidence demonstrates limited V3 as well as Voe domain usage by class I-and class II-restricted T cell clones and hybridomas recognizing specific antigen-MHC complexes (reviewed by Casanova and Maryanski [55] , and references therein). The peptide(s) recognized by the V36 + anti-polyoma CTL are most likely derived from the MT and/or LT protein(s) of polyoma virus. Recombinant vaccinia viruses carrying MT or LT coding sequences as well as synthetic MT or LT peptides immunize rodents against transplanted polyoma-induced tumors (56, 57) . Polyoma tumors invariably express MT, consistent with the essential role this prorein plays in cellular transformation (58, 59) , tumor induction (60) , and virion assembly (61) . LT is also generally expressed, though often in a truncated form, while viral capsid proteins are either not expressed or expressed nonuniformly in polyoma tumors (25) . Because the polyoma tumor target cells used here (Fig. 5 ) express only T proteins, the latter must provide the TSTAs for the polyoma-specific CDS+V36 + CTLs in C57BR/cdJ mice (Tables 3 and 5) . Attempts are underway to identify the T antigen peptide(s) recognized by these CTLs.
The identification of Pyv s as Mtv-7 sag represents a third manifestation of the function of this gene, having first been discovered as encoding the minor lymphocyte stimulating antigen Mls-1 a (28, 40) . A number of interesting questions can be raised concerning the biological significance of these nonessential but widely distributed proviral genes which encode superantigens. Though clearly a susceptibility factor vis-avis experimental infection with polyoma virus, Mtv SAGs work in the opposite way, as determinants of resistance, with respect to infection by exogenous Mtvs. These viruses are lymphotropic and depend on SAG-mediated T cell activation in their life cycle (62) . Mice carrying a particular Mtv provirns undergo deletion of those T cells required for replication by the homologous Mtv (63) . While the presence of germline proviruses may reflect an evolutionary mechanism for protection against horizontal transmission of Mtvs, it also appears to carry a potential risk of increasing susceptibility to unrelated infectious agents. A larger question concerns the possibility that endogenous superantigens other than Mtv SAGs exist, and in species other than the mouse, and that such genes may act in a similar manner to influence susceptibility to disease.
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